Elevate Ventures Job Board

Neurodon is the only company harnessing and restoring Ca2+ with first-in-class modulators. Neurodon’s compounds have undergone extensive proof-of-concept studies in animal models of diabetes, obesity, neurodegenerative disorders, and rare diseases. There are no competitors in the market targeting diseases with Neurodon’s MOA and industry-leading ER stress platform technology. We have 2 candidates in IND-enabling studies and plan to enter the clinic in 2025. Neurodon has raised over $11MM to date through a combination of state and federal grants (e.g., NIH), foundations (e.g., JDRF), partnerships, angel investments, and founder’s funds. Neurodon is currently raising a funding round to fund first-in-human studies for its diabetes and rare disease programs in 2025.

Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Elevate Ventures network.

Claim your profile now

Something looks off?

Open jobs at Neurodon

This company does not have jobs relevant to this job board at this time.

To view all their jobs, visit their website.

Privacy policy Cookie policy

We invest in cross-sector innovation-driven enterprises through our core pillars of Community, Capital and Acceleration.

As the #1 seed and early-stage venture capital firm in the Great Lakes Region and Top 20 in the World, we are building a robust innovation ecosystem with companies, customers and mission-critical partners that fuel founders.

GET IN TOUCH